What's new in psoriasis? Analysis of the clinical significance of new guidelines and systematic reviews on psoriasis published in 2008 and 2009

被引：5

作者：

Warren, R. B. ^{[1
]}

Brown, B. C. ^{[1
]}

Grindlay, D. J. C. ^{[2
]}

Griffiths, C. E. M. ^{[1
]}

机构：

[1] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England

[2] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2010年 / 35卷 / 07期

关键词：

MEDICAL BOARD; FOUNDATION; THERAPY; DISEASE;

D O I：

10.1111/j.1365-2230.2010.03880.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P>This review summarizes the clinical importance of 18 systematic reviews and guidelines on psoriasis published or indexed between November 2008 and October 2009. The topics covered include guidance on the use of topical, systemic and biological therapies for the treatment of psoriasis; comorbidities associated with psoriasis; and complementary therapies for psoriasis. A similar and more detailed review to this appeared in the 2009 Annual Evidence Update on Psoriasis from NHS Evidence - Skin Disorders in November 2009.

引用

页码：688 / 692

页数：5

共 22 条

[1] Treatment of severe scalp psoriasis: From the Medical Board of the National Psoriasis Foundation [J].

Chan, C. Stanley ;

Van Voorhees, Abby S. ;

Lebwohl, Mark G. ;

Korman, Neil J. ;

Young, Melodic ;

Bebo, Bruce F., Jr. ;

Kalb, Robert E. ;

Hsu, Sylvia .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (06) :962-971

[2] Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action [J].

Collamer, Angelique N. ;

Guerrero, Karen T. ;

Henning, Jeffery S. ;

Battafarano, Daniel F. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (07) :996-1001

[3] Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-α inhibitors for patients with severe psoriasis [J].

Dharamsi, J. W. ;

Bhosle, M. ;

Balkrishnan, R. ;

Yentzer, B. A. ;

Feldman, S. R. .

BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (03) :605-616

[4] The therapeutic effect of balneotherapy: evaluation of the evidence from randomised controlled trials [J].

Falagas, M. E. ;

Zarkadoulia, E. ;

Rafailidis, P. I. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (07) :1068-1084

[5] Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease [J].

Fiorino, G. ;

Allez, M. ;

Malesci, A. ;

Danese, S. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (09) :921-927

[6]

Green S., 2004, COCHRANE HDB SYSTEMA

[7] Psoriasis 1 - Pathogenesis and clinical features of psoriasis [J].

Griffiths, Christopher E. M. ;

Barker, Jonathan N. W. N. .

LANCET, 2007, 370 (9583) :263-271

[8] Treatment of intertriginous psoriasis: From the Medical Board of the National Psoriasis Foundation [J].

Kalb, Robert E. ;

Bagel, Jerry ;

Korman, Neil J. ;

Lebwohl, Mark G. ;

Young, Melodie ;

Horn, Elizabeth J. ;

Van Voorhees, Abby S. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (01) :120-124

[9] Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases [J].

Ko, Justin M. ;

Gottlieb, Alice B. ;

Kerbleski, Joseph F. .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2009, 20 (02) :100-108

[10] Infliximab for the treatment of adults with psoriasis [J].

Loveman, E. ;

Turner, D. ;

Hartwell, D. ;

Cooper, K. ;

Clegg, A. .

HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 :55-60

← 1 2 3 →